Atlas Trials

START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism

Clinical trial NCT00132431 · COMPLETED

Trial details

NCT number
NCT00132431
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney DiseaseSecondary HyperparathyroidismChronic Kidney Disease
Start date
2004-07-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.